×

ZSAN – zosana pharma corp (US:NASDAQ)

DELAYED
$ usd
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day ZSAN SPY QQQ SPX
Date Time Symbol Headline Impact
8/10 04:01 pm zsan Zosano Pharma Reports Second Quarter 2017 Financial Results and Operational Update Medium
8/10 03:30 pm zsan Investor Network: Zosano Pharma Corp. to Host Earnings Call Low
8/2 08:30 am zsan Zosano Pharma to Host Conference Call on Second Quarter 2017 Financial Results and Provide Operational Update Medium
7/31 09:30 am zsan Zosano Announces Publication of Positive Phase 1 Data of Zolmitriptan Delivery In Future Medicine’s Pain Management Journal Medium
7/13 11:23 am zsan ROTY Edition 1 Volume 11: Our First Sell [Seeking Alpha] Medium
6/26 08:30 am zsan Zosano Pharma Announces Outcome of End of Phase 2 Meetings with FDA Low
6/14 04:01 pm zsan Zosano Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) Medium
6/12 09:12 am zsan BRIEF-Zosano Pharma updates on additional data from Zotrip study [Reuters] Medium
6/6 03:00 pm zsan Zosano Pharma Corp (NASDAQ: ZSAN) was upgraded by analysts at ValuEngine from a "strong sell" rating to a "sell" rating. Neutral
6/1 08:30 am zsan Zosano to Present Migraine Data at Three Industry-Leading Conferences Medium
5/26 09:25 am zsan Zosano up 6% premarket after execs buy shares [Seeking Alpha] Medium
5/12 08:40 pm zsan Zosano Pharma's (ZSAN) CEO John Walker on Q1 2017 Results - Earnings Call Transcript [Seeking Alpha] Low
5/9 04:00 pm zsan Zosano Reports First Quarter 2017 Financial Results and Announces Management Changes High
5/9 03:05 pm zsan Investor Network: Zosano Pharma Corp. to Host Earnings Call Medium
5/8 05:30 am zsan Zosano Pharma to Host Conference Call on First Quarter 2017 Financial Results and Provide Operational Update Low
3/24 05:21 am zsan Zosano Pharma Corp (NASDAQ: ZSAN) is now covered by analysts at Piper Jaffray Companies. They set an "overweight" rating on the stock. Low
3/22 04:01 pm zsan Zosano Announces Closing of Public Offering of Common Stock and Exercise of Underwriters’ Over-Allotment Option Medium
3/17 09:25 am zsan Zosano Announces Pricing of Public Offering of Common Stock Low
3/12 08:17 pm zsan Zosano Pharma Corp (NASDAQ: ZSAN) was given a new $3.00 price target on by analysts at Roth Capital. They now have a "buy" rating on the stock. Medium
3/1 07:25 am zsan Zosano Pharma misses by $0.01 [Seeking Alpha] Medium
2/28 07:47 am zsan Zosano Pharma: There Is More Upside Despite Recent Run-Up [Seeking Alpha] Medium
2/13 08:30 am zsan Zosano Pharma Announces 3.8mg Dose of M207, its Novel Transdermal Therapeutic, Meets Both Co-primary Endpoints in the ZOTRIP Pivotal Efficacy Trial in Migraine High
1/23 05:18 pm zsan Zosano Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4) Neutral
1/18 08:57 am zsan Zosano Pharma Corporation (NASDAQ: ZSAN) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. Medium
1/5 08:30 am zsan Zosano Pharma Announces Last Subject Treated in its Migraine Pivotal Trial High
12/1 11:25 am zsan Medicure closes Apicore transaction [Seeking Alpha] Low
11/22 07:24 pm zsan BRIEF-Zosano Pharma announces sale of non-strategic asset [Reuters] Low
11/22 03:52 pm zsan Zosano Pharma divests Zosano, Inc. to foreign investors [Seeking Alpha] Neutral
11/18 07:19 am zsan Zosano Pharma Corp. (NASDAQ: ZSAN) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $0.75 price target on the stock. Low
11/16 02:45 pm zsan BRIEF-Rosalind Advisors reports 11.2 pct passive stake in Zosano Pharma [Reuters] Low
11/9 04:20 pm zsan Zosano Pharma Reports Third Quarter 2016 Financial Results High
11/8 11:40 am zsan Zosano Pharma announces completion of enrollment in pivotal efficacy trial for M207 for acute migraine [Seeking Alpha] Medium
10/25 09:59 am zsan Zosano Pharma Corp. (NASDAQ: ZSAN) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. Low
9/9 04:45 pm zsan BRIEF-Zosano files for resale of up to 14.44 mln shares of co's common stock by selling stockholders [Reuters] Low
9/8 08:30 am zsan Zosano Appoints Georgia Erbez as Chief Business Officer Low
8/31 08:52 am zsan Zosano Pharma Corp. (NASDAQ: ZSAN) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. High
8/26 05:31 pm zsan ALERT: Rosen Law Firm Continues to Investigate Securities Claims Against Zosano Pharma Corporation Medium
8/25 07:21 am zsan Zosano Pharma Corp. (NASDAQ: ZSAN) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. Medium
Date Time Symbol Company Name Action %Chg
8/10 04:01 pm ZSAN zosana pharma corp MISS -9.6%
3/1 07:00 am ZSAN zosana pharma corp MISS -4.8%
11/9 04:20 pm ZSAN zosana pharma corp BEAT 14.3%
Date Time Action From To Firm Impact %CHG DETAILS
6/6 03:00 pm Upgrades Strong Sell Sell ValuEngine 0.0%
3/24 05:21 am Initiates Overweight Piper Jaffray Companies Low -1.1%
1/18 08:57 am Downgrades Buy Hold Zacks Investment Research Medium 6.5%
11/18 07:19 am Upgrades Hold Buy Zacks Investment Research Low 0.9%
10/25 09:59 am Upgrades Sell Hold Zacks Investment Research Low 1.6%
8/31 08:52 am Downgrades Hold Sell Zacks Investment Research High -13.4%
8/25 07:21 am Downgrades Hold Sell Zacks Investment Research Medium -3.4%
Date Time Symbol Headline Impact
8/11 07:19 pm zsan Form 4 Zosano Pharma Corp For: Aug 09 Low
8/10 04:17 pm zsan Form 8-K Zosano Pharma Corp For: Aug 10 Medium
6/9 04:07 pm zsan Form 8-K Zosano Pharma Corp For: Jun 06 Medium
6/5 04:28 pm zsan Form 8-K Zosano Pharma Corp For: May 31 Low
5/26 05:54 pm zsan Form 4/A Zosano Pharma Corp For: May 24 Filed by: WALKER JOHN PETER Medium
5/25 08:47 pm zsan Form 4 Zosano Pharma Corp For: May 24 Filed by: WALKER JOHN PETER High
5/24 04:11 pm zsan Form 8-K/A Zosano Pharma Corp For: May 18 Low
5/22 06:26 pm zsan Form 4 Zosano Pharma Corp For: May 18 Filed by: WALKER JOHN PETER Low
5/9 04:06 pm zsan Form 8-K Zosano Pharma Corp For: May 08 High
5/8 06:13 pm zsan Form 4 Zosano Pharma Corp For: May 04 Filed by: WALKER JOHN PETER Low
5/5 05:21 pm zsan Form 8-K Zosano Pharma Corp For: May 02 Low
4/28 04:38 pm zsan Form DEF 14A Zosano Pharma Corp For: May 31 Medium
4/12 07:22 pm zsan Form 4 Zosano Pharma Corp For: Apr 10 Filed by: Tso Winnie Wing-Kei Low
4/10 05:14 pm zsan Form 8-K Zosano Pharma Corp For: Apr 10 Low
4/10 10:32 am zsan Form SC 13G/A Zosano Pharma Corp Filed by: FMR LLC Low
3/29 06:02 am zsan Form SC 13G/A Zosano Pharma Corp Filed by: Rosalind Advisors, Inc. Low
3/28 03:00 pm zsan Form SC 13G/A Zosano Pharma Corp Filed by: Amzak Capital Management, LLC Medium
3/22 05:39 pm zsan Form 4 Zosano Pharma Corp For: Mar 20 Filed by: Alataris Konstantinos Medium
3/20 05:01 pm zsan Form 424B4 Zosano Pharma Corp Medium
3/20 06:01 am zsan Form EFFECT Zosano Pharma Corp Medium
3/17 08:55 am zsan Form 8-K Zosano Pharma Corp For: Mar 17 Medium
3/13 06:07 am zsan Form S-1/A Zosano Pharma Corp Medium
3/6 06:03 am zsan Form 10-K/A Zosano Pharma Corp For: Dec 31 Medium
3/2 05:22 pm zsan Form S-1 Zosano Pharma Corp Medium
3/1 07:31 am zsan Form 8-K Zosano Pharma Corp For: Mar 01 Medium
2/14 06:26 pm zsan Form 4 Zosano Pharma Corp For: Feb 13 Filed by: BARRETT M JAMES High
2/14 12:13 pm zsan Form SC 13G/A Zosano Pharma Corp Filed by: FMR LLC Medium
1/25 04:36 pm zsan Form 8-K Zosano Pharma Corp For: Jan 24 Low
1/5 01:24 pm zsan Form SC 13G Zosano Pharma Corp Filed by: Amzak Capital Management, LLC Medium
11/22 05:15 pm zsan Form 8-K Zosano Pharma Corp For: Nov 22 Low
11/16 01:20 pm zsan Form SC 13G Zosano Pharma Corp Filed by: Rosalind Advisors, Inc. Low
11/9 04:34 pm zsan Form 8-K Zosano Pharma Corp For: Nov 09 High
11/4 05:18 pm zsan Form 4 Zosano Pharma Corp For: Nov 02 Filed by: Hagan Joseph P Low
11/3 04:14 pm zsan Form 8-K Zosano Pharma Corp For: Nov 02 Medium
10/17 04:57 pm zsan Form SC 13G Zosano Pharma Corp Filed by: ARMISTICE CAPITAL, LLC Medium
10/14 04:09 pm zsan Form 8-K Zosano Pharma Corp For: Oct 12 Medium
10/7 04:17 pm zsan Form DEF 14A Zosano Pharma Corp For: Nov 02 Neutral
9/26 06:01 am zsan Form EFFECT Zosano Pharma Corp Low
9/20 04:39 pm zsan Form 4 Zosano Pharma Corp For: Sep 16 Filed by: NEA Partners 12, Limited Partnership Medium
9/15 04:31 pm zsan Form 4 Zosano Pharma Corp For: Sep 13 Filed by: BARRETT M JAMES Low
9/9 04:14 pm zsan Form S-3 Zosano Pharma Corp Low
8/31 04:36 pm zsan Form 4 Zosano Pharma Corp For: Aug 29 Filed by: BARRETT M JAMES Low
8/29 10:39 am zsan Form D Zosano Pharma Corp Low
Stock Stats
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny

Odd Lot

Avg. bid-ask spread

Avg. bid / ask size


Shares at ask / bid


Off exchange

Don’t Miss Out On The Next BIG Stock Move

Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.